drugset / Trial / NCT01830478
Lenalidomide Plus Rituximab (R) in Non Follicular NHL
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether lenalidomide in association with rituximab is effective in the treatment of patients with indolent non follicular NHL relapsed after \>=2, but less than 4 prior lines of (immuno)chemotherapy.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-12
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | 20 mg | Oral |
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | Intravenous |